Thomas Aparicio

29PUBLICATIONS
109CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Apr 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

|Mar 20, 2026
Humanized avian embryo models replicate an immune tumor environment for rapid immunotherapy studies.

Marjorie Lacourrège, Loraine Jarrosson, Clélia Costechareyre

|Feb 17, 2026
Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|Jan 07, 2026
Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|May 14, 2025
Geriatric Assessment and Management, Prehabilitation and Rehabilitation for Older Aldults with Non-Colorectal Digestive Cancers.

Amélie Aregui, Janina Estrada, Madeleine Lefèvre

Pageof 5

Frequent Collaborators

11 joint publications

David Tougeron

3 joint publications

Julien Taieb

3 joint publications

Karine Le Malicot

3 joint publications

Pierre Laurent-Puig